Skip to main content

Antidepressants

  • Chapter
  • First Online:
Principles of Forensic Toxicology
  • 3567 Accesses

Abstract

Antidepressants, as the name implies, are drugs used to treat depression and are widely used therapeutic agents. They are also some of the most frequently encountered drugs in forensic and clinical toxicology. Antidepressants are often characterized based on when they were developed: first-generation antidepressants, second-generation antidepressants, selective serotonin reuptake inhibitors, and third-generation antidepressants. All of the antidepressants are well absorbed and reach peak serum concentrations within 2–12 h, but there is considerable first-pass metabolism with most of these drugs. They are rather lipophilic and have large volumes of distribution. In general, these drugs are extensively metabolized by cytochrome P450 isoenzymes to demethylated and hydroxylated metabolites, many of which are active. Analysis of these compounds in biological specimens requires specimen preparation either by liquid–liquid extraction or solid-phase extraction. Chromatographic separation by gas or liquid chromatography allows simultaneous analysis of most antidepressants and their major metabolites. First-generation antidepressants are associated with greater toxicity, primarily due to anticholinergic effects, central nervous system effects, and cardiovascular effects. Interpretation of postmortem concentrations of these drugs is complicated by postmortem redistribution; therefore, the use of therapeutic ranges established for antemortem serum is inappropriate.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 84.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  • Apter JT, Greenberg WM (1994) New drug development in psychiatry. J Clin Res Drug Dev 8:87–100

    Google Scholar 

  • Balant-Gorgia AE, Balant LP (1992) Therapeutic drug monitoring of antidepressants. Clin Ther 14(4):612–614

    CAS  PubMed  Google Scholar 

  • Cole JO, Bodkin JA (1990) Antidepressant drug side effects. J Clin Psychiatry 51(suppl):21–26

    PubMed  Google Scholar 

  • Devane CL (1987) Monitoring cyclic antidepressants. Clin Lab Med 7(3):551–566

    Article  CAS  Google Scholar 

  • Devane CL (1994) Pharmacokinetics of the newer antidepressants: clinical relevance. Am J Med 97(6A):13S–23S

    Article  CAS  Google Scholar 

  • Duman RS, Heninger GR, Nestler EJ (1977) A molecular and cellular theory of depression. Arch Gen Psychiatry 54(7):597–606

    Article  Google Scholar 

  • Ereshefsky L, Riesenman C, Lam YWF (1996) Serotonin selective reuptake inhibitor drug interactions and the cytochrome P450 system. J Clin Psychiatry 57(suppl 8):17–25

    CAS  PubMed  Google Scholar 

  • Frazer A (1997) Pharmacology of antidepressants. J Clin Psychopharmacol 17(suppl 1):2S–8S

    Article  CAS  Google Scholar 

  • Furlanut M, Benetello P, Spina E (1993) Pharmacokinetic optimisation of tricyclic antidepressant therapy. Clin Pharmacokinet 24(4):301–318

    Article  CAS  Google Scholar 

  • Hebb JH, Caplan YH, Crooks CR, Mergner WJ (1982) Blood and tissue concentrations of tricyclic antidepressant drugs in postmortem cases: literature survey and a study of forty deaths. J Anal Toxicol 6:209–216

    Article  CAS  Google Scholar 

  • Hyman SE, Nestler EJ (1996) Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry 153(2):151–162

    Article  CAS  Google Scholar 

  • Jones GR, Pounder DJ (1987) Site dependence of drug concentrations in postmortem blood—a case study. J Anal Toxicol 11:184–190

    Google Scholar 

  • Joron S, Rogert H (1994) Simultaneous determination of antidepressant drugs and metabolites by HPLC. Design and validation of a simple and reliable analytical procedure. Biomed Chromatogr 8(4):158–164

    Article  CAS  Google Scholar 

  • McIntyre IM, King CV, Skafidis S, Drummer OH (1993) Dual ultraviolet wavelength high-performance liquid chromatographic method for the forensic or clinical analysis of seventeen antidepressants and some selected metabolites. J Chromatogr 621(2):215–223

    Article  CAS  Google Scholar 

  • Nemeroff CB, Devane CL, Pollock BG (1996) Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 153(3):311–320

    Article  CAS  Google Scholar 

  • O’Toole SM, Johnson DA (1997) Psychobiology and psychopharmacotherapy of unipolar major depression; a review. Arch Psychiatr Nurs 6:304–313

    Article  Google Scholar 

  • Owens MJ (1996) Molecular and cellular mechanisms of antidepressant drugs. Depress Anxiety 4:153–159

    Article  Google Scholar 

  • Preskorn SH (1997) Clinically relevant pharmacology of selective serotonin reuptake inhibitors. Clin Pharmacokinet 32(suppl 1):1–21

    Article  CAS  Google Scholar 

  • Preskorn SH (1993) Pharmacokinetics of antidepressants: why and how they are relevant to treatment. J Clin Psychiatry 54(suppl:14–34):55–56

    Google Scholar 

  • Prouty RW, Anderson WH (1990) The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J Forensic Sci 35(2):243–270

    Article  CAS  Google Scholar 

  • Richelson E (1997) Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs. Mayo Clin Proc 72:835–847

    Article  CAS  Google Scholar 

  • Stahl SM (1998) Basic psychopharmacology of antidepressants, Part 1: antidepressants have seven distinct mechanisms of action. J Clin Psychiatry 59(suppl 4):5–14

    CAS  PubMed  Google Scholar 

  • Spina E, Santoro V, D’Arrigo C (2008) Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants—a review. Clin Ther 30(7):1206–1227

    Article  CAS  Google Scholar 

  • Swanson JR, Jones GR, Krasselt W, Denmark LN, Ratti F (1997) Death of two subjects due to imipramine and desipramine metabolite accumulation during chronic therapy: a review of the literature and possible mechanisms. J Forensic Sci 42(2):335–339

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William H. Anderson .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Anderson, W.H. (2020). Antidepressants. In: Levine, B.S., KERRIGAN, S. (eds) Principles of Forensic Toxicology. Springer, Cham. https://doi.org/10.1007/978-3-030-42917-1_27

Download citation

Publish with us

Policies and ethics